Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Biosign Technologies Inc BITKF

Biosign Technologies Inc is a Canada based company engaged in the development and selling of cloud-based medical and healthcare software products. Its solutions have applications in clinic management, home care operations, health monitoring and virtual care management. The group derives its revenue from monthly recurring fees, one-time setup charges, training, professional services and the sale of hardware. The software is delivered through the cloud from the company's hosting facilities.


GREY:BITKF - Post by User

Comment by nomadtraderon Jan 20, 2015 11:07am
180 Views
Post# 23339133

RE:News

RE:NewsThey are quietly making progress and justifying increased expenses. The excerpt below from Page 16 of the Biosign MD&A November 29, 2014 refers to the increased expense of developing the enterprise functionality for the ClinicServer platform. Today's news certainly is a positive indication that the development money spent will be adding to the bottom line in increased revenue. Hopefully the next news will refer to the progress of the Aiomed platform being rolled out into some of those 600 nursing homes and extended care facilities in Germany that according to the same except began in September 2014. When the news hits the Aiomed platform has been deployed and generating revenue I expect that the current share price level will be gone for good.

From Page 16 of Biosign MD&A November 29, 2014:
"Increased costs have also been incurred in connection with the development of enterprise functionality for the ClinicServer platform and development efforts of Aiomed platform prior to customer rollout which started in September 2014".
<< Previous
Bullboard Posts
Next >>